Evidence map›Paper›PMID 36816916›Full record

ArticleFrontiers in oncology2023

Deep learning of bone metastasis in small cell lung cancer: A large sample-based study.

Qing Chen, Haifeng Liang, Lei Zhou, Hongwei Lu, Fancheng Chen, Yuxiang Ge, Zhichao Hu, Ben Wang, Annan Hu, Wei Hong and 2 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Current and future therapies for small cell lung carcinoma.Journal of hematology & oncology · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Qing ChenDepartment of Orthopedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Haifeng LiangDepartment of Orthopedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Lei ZhouDepartment of Orthopedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Hongwei LuDepartment of Orthopedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Fancheng ChenDepartment of Orthopedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Yuxiang GeDepartment of Orthopedics Surgery, Minhang Hospital, Fudan University, Shanghai, China.
Zhichao HuDepartment of Orthopedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Ben WangDepartment of Orthopedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Annan HuDepartment of Orthopedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Wei HongDepartment of Geriatrics and Gerontology, Huadong Hospital, Fudan University, Shanghai, China.
Libo JiangDepartment of Orthopedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Jian DongDepartment of Orthopedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Bone is a common metastatic site for small cell lung cancer (SCLC). Bone metastasis (BM) in patients have are known to show poor prognostic outcomes. We explored the epidemiological characteristics of BM in SCLC patients and create a new deep learning model to predict outcomes for cancer-specific survival (CSS) and overall survival (OS). Materials and Methods: Data for SCLC patients diagnosed with or without BM from 2010 to 2016 were retrieved from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate Cox proportional hazards regression models were used to evaluate the effects of prognostic variables on OS and CSS. Through integration of these variables, nomograms were created for the prediction of CSS and OS rates at 3-month,6- month,and 12-month. Harrell's coordination index, calibration curves,and time- dependent ROC curves were used to assess the nomograms' accuracy. Decision tree analysis was used to evaluate the clinical application value of the established nomogram. Results: In this study, 4201 patients were enrolled. Male sex, tumor size 25 but <10, brain and liver metastases, as well as chemotherapy were associated with a high risk for BM. Tumor size, Age, N stage, gender, liver metastasis, radiotherapy as well as chemotherapy were shown to be prognostic variables for OS, and the prognostic variables for CSS were added to the tumor number in addition. Based on these results, nomograms for CSS and OS were established separately. Internal as well as external validation showed that the C-index, calibration cuurve and DCA had good constructive correction effect and clinical application value. Decision tree analysis further confirmed the prognostic factors of OS and CSS. Discussion: The nomogram and decision tree models developed in this study effectively guided treatment decisions for SCLC patients with BM. The creation of prediction models for BM SCLC patients may be facilitated by deep learning models.

Indexed as

bone metastasisdecision treenomogramsmall cell lung cancersurvival

Identifiers

PMID36816916
PMCPMC9931187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.